Insider Transactions in Q1 2024 at Neoleukin Therapeutics, Inc. (NLTX)

NLTX Quotes by TradingView

Insider Transaction List (Q1 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Mar 13 2024
Stuart Cobb Chief Scientific Officer
BUY
Grant, award, or other acquisition
Direct
20,391 +50.0%
-
Mar 13 2024
Christine Mikail Cvijic President and CFO
BUY
Grant, award, or other acquisition
Direct
31,903 +37.65%
-

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NLTX